The TM-Pilot Program (formerly known as Novel Method Development) supports the development of novel methods and innovative technologies for clinical and translational research. This includes the development of new assays, methods or technologies which are not currently available to the CU Anschutz campus and CCTSI affiliated institutions.
Applications with two co-PIs, one for technology development and another for a scientific application, are especially encouraged to ensure future application and dissemination of newly developed technologies.
The TM-Pilot Request for Funding (RFA) is issued in October, applications due in December, and awards are selected in February. The active funding period is May through April. Exact dates are listed in the Key Dates section of this page.
Multiple TM-Pilot awards of up to $20,000 each will be awarded in these categories:
The RFA describes eligibility, award categories and application requirements.
The CCTSI Pilot Grants Program team is working remotely to issue all new Notices of Award for the CO-Pilot, Child and Maternal Health Pilot, Translational Methods Pilot, and the Community Engagement pilot programs. Our goal is for all investigators conducting Human Subjects or Vertebrate Animals research to have their institutional regulatory compliance approvals in place by May 1, 2020 (if possible). At this time, we plan to issue awards with 12-month budget period (5/1/20-4/30/21); we understand that COVID-19 restrictions related to research and lab access may cause delays in your ability to actually begin the project; we will be taking that into account to approve no-cost extensions (if necessary) as the budget period end-date approaches. For any questions pertaining to the CCTSI Pilot Grant Programs, email Debra Szuster.
October 7, 2019
Meeting ID: 931 927 4660
November 13, 1:00 - 2:00 pm MST
Mandatory Intent-to-Apply Form (LOI)
Application Review Period
Notice of Selection
Project Funding Period